These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 9050821)
1. Pathophysiology and pharmacological approaches for prevention of coronary artery restenosis following coronary artery balloon angioplasty and related procedures. Landzberg BR; Frishman WH; Lerrick K Prog Cardiovasc Dis; 1997; 39(4):361-98. PubMed ID: 9050821 [TBL] [Abstract][Full Text] [Related]
2. Novel approaches for the prevention of restenosis. Gruberg L; Waksman R; Satler LF; Pichard AD; Kent KM Expert Opin Investig Drugs; 2000 Nov; 9(11):2555-78. PubMed ID: 11060820 [TBL] [Abstract][Full Text] [Related]
3. Impact of cilostazol on restenosis after percutaneous coronary balloon angioplasty. Tsuchikane E; Fukuhara A; Kobayashi T; Kirino M; Yamasaki K; Kobayashi T; Izumi M; Otsuji S; Tateyama H; Sakurai M; Awata N Circulation; 1999 Jul; 100(1):21-6. PubMed ID: 10393676 [TBL] [Abstract][Full Text] [Related]
4. Ischemia: reperfusion injury and restenosis after coronary angioplasty. Park JW; Braun P; Mertens S; Heinrich KW Ann N Y Acad Sci; 1992 Sep; 669():215-36. PubMed ID: 1444028 [TBL] [Abstract][Full Text] [Related]
5. Restenosis after percutaneous transluminal coronary angioplasty: have we been aiming at the wrong target? Currier JW; Faxon DP J Am Coll Cardiol; 1995 Feb; 25(2):516-20. PubMed ID: 7829808 [TBL] [Abstract][Full Text] [Related]
10. [Restenosis after coronary angioplasty: its pathogenesis and prevention]. Marzocchi A; Marrozzini C; Piovaccari G; Fattori R; Castriota F; D'Anniballe G; Branzi A; Magnani B Cardiologia; 1991 Dec; 36(12 Suppl 1):309-20. PubMed ID: 1841786 [TBL] [Abstract][Full Text] [Related]
11. The role of platelets, thrombin and hyperplasia in restenosis after coronary angioplasty. Ip JH; Fuster V; Israel D; Badimon L; Badimon J; Chesebro JH J Am Coll Cardiol; 1991 May; 17(6 Suppl B):77B-88B. PubMed ID: 2016486 [TBL] [Abstract][Full Text] [Related]
12. The paradigm of restenosis following percutaneous transluminal coronary angioplasty. Preisack MB; Karsch KR Eur Heart J; 1993 Nov; 14 Suppl I():187-92. PubMed ID: 8293774 [TBL] [Abstract][Full Text] [Related]
13. Restenosis after percutaneous transluminal coronary angioplasty--anatomic and pathophysiological mechanisms. Strategies for prevention. Block PC Circulation; 1990 Mar; 81(3 Suppl):IV2-4. PubMed ID: 2407372 [TBL] [Abstract][Full Text] [Related]
14. Effect of cilostazol in preventing restenosis after percutaneous transluminal coronary angioplasty. Take S; Matsutani M; Ueda H; Hamaguchi H; Konishi H; Baba Y; Kawaratani H; Sugiura T; Iwasaka T; Inada M Am J Cardiol; 1997 Apr; 79(8):1097-9. PubMed ID: 9114771 [TBL] [Abstract][Full Text] [Related]
16. Prevention of restenosis after coronary balloon angioplasty: rationale and design of the Fluvastatin Angioplasty Restenosis (FLARE) Trial. The FLARE Study Group. Foley DP; Bonnier H; Jackson G; Macaya C; Shepherd J; Vrolix M; Serruys PW Am J Cardiol; 1994 May; 73(14):50D-61D. PubMed ID: 8198025 [TBL] [Abstract][Full Text] [Related]